Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Filters applied: . Clear all
Page 1
Role of atypical bacteria and azithromycin therapy for children with recurrent respiratory tract infections.
Esposito S, Bosis S, Faelli N, Begliatti E, Droghetti R, Tremolati E, Porta A, Blasi F, Principi N. Esposito S, et al. Among authors: faelli n. Pediatr Infect Dis J. 2005 May;24(5):438-44. doi: 10.1097/01.inf.0000160949.99560.8d. Pediatr Infect Dis J. 2005. PMID: 15876944 Clinical Trial.

RESULTS: Atypical bacterial infections were identified for 190 patients (54.0%) and 8 healthy control subjects (3.8%; P < 0.0001). Short term (1-month) clinical success was significantly more frequent among the patients who had received azithromycin together with sympto

RESULTS: Atypical bacterial infections were identified for 190 patients (54.0%) and 8 healthy control subjects (3.8%; P < 0.0001). Short

Recurrent respiratory tract infections in pediatric age: a population-based survey of the therapeutic role of macrolides.
Principi N, Esposito S, Cavagna R, Bosis S, Droghetti R, Faelli N, Tosi S, Begliatti E; Snoopy Study Group. Principi N, et al. Among authors: faelli n. J Chemother. 2003 Feb;15(1):53-9. doi: 10.1179/joc.2003.15.1.53. J Chemother. 2003. PMID: 12678415
Regardless of age and clinical diagnosis, the children treated with macrolides showed a significantly higher rate of short- and long-term clinical success than those receiving beta-lactams (p<0.0001) or symptomatics alone (p<0.0001). ...
Regardless of age and clinical diagnosis, the children treated with macrolides showed a significantly higher rate of short- and long-term